{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:42:22Z","timestamp":1774680142519,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jinf.2009.11.011","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T04:45:21Z","timestamp":1259901921000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong"],"prefix":"10.1016","volume":"60","author":[{"given":"Pak-Leung","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui-Ying","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin-Hung","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen L.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent C.C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Y.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2009.11.011_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-0711-5-2","article-title":"Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States","volume":"5","author":"Styers","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jinf.2009.11.011_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib3","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib4","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7\u2013A6","author":"Clinical and Laboratory Standard Institute","year":"2006"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2009.11.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(08)70002-5","article-title":"Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus","volume":"31","author":"Gould","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2009.11.011_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001\u201305","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib7","series-title":"Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100\u2013S19","author":"Clinical and Laboratory Standard Institute","year":"2009"},{"key":"10.1016\/j.jinf.2009.11.011_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/01.CCM.0000059437.01924.97","article-title":"Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission","volume":"31","author":"Ho","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jinf.2009.11.011_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/520429","article-title":"Bacteremia caused by staphylococci with inducible vancomycin heteroresistance","volume":"29","author":"Wong","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/JCM.39.2.574-580.2001","article-title":"Comparison of DNA sequencing of the protein A gene polymorphic region with other molecular typing techniques for typing two epidemiologically diverse collections of methicillin-resistant Staphylococcus aureus","volume":"39","author":"Oliveira","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2009.11.011_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1086\/517951","article-title":"Epidemiology and genetic diversity of methicillin-resistant Staphylococcus aureus strains in residential care homes for elderly persons in Hong Kong","volume":"28","author":"Ho","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2009.11.011_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2007.12.017","article-title":"Molecular epidemiology of methicillin-resistant Staphylococcus aureus in residential care homes for the elderly in Hong Kong","volume":"61","author":"Ho","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.diagmicrobio.2006.08.003","article-title":"Molecular epidemiology and household transmission of community-associated methicillin-resistant Staphylococcus aureus in Hong Kong","volume":"57","author":"Ho","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.diagmicrobio.2007.12.015","article-title":"Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong","volume":"61","author":"Ho","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.diagmicrobio.2009.01.030","article-title":"Changes in the epidemiology of methicillin-resistant Staphylococcus aureus associated with spread of the ST45 lineage in Hong Kong","volume":"64","author":"Ho","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib16","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/430175","article-title":"Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux","volume":"40","author":"Rhee","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dki486","article-title":"Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983\u20132002","volume":"57","author":"Robert","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib18","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2009.11.011_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/dkn246","article-title":"Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage","volume":"62","author":"Alos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib20","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/AAC.00616-09","article-title":"Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib22","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","article-title":"Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy","volume":"38","author":"Moise-Broder","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/dkp047","article-title":"Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies","volume":"63","author":"Moise","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/dkm445","article-title":"Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia","volume":"61","author":"Moise","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib25","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2009.11.011_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jinf.2009.11.011_bib27","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2009.11.011_bib28","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JCM.00407-09","article-title":"Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005","volume":"47","author":"Mason","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2009.11.011_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2009.11.011_bib30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2009.11.011_bib31","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years","volume":"47","author":"Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2009.11.011_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkl151","article-title":"Comparison of four methods for detection of teicoplanin resistance in methicillin-resistant Staphylococcus aureus","volume":"58","author":"Charlesworth","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445309003685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445309003685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:13:41Z","timestamp":1759007621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445309003685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0163445309003685"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2009.11.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13485030.14862157","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2009.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}